# Pandect Bioventures

Pandect Bioventures is a Venture Capital based in Woodside, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Woodside, United States
- **Region:** North America
- **Address:** South San Francisco, CA, United States
- **Founded:** 2016
- **Assets under management:** Undisclosed
- **Website:** pandectbio.com
- **LinkedIn:** https://www.linkedin.com/company/pandectbio

## Regulatory record

- **CRD number:** 300039
- **SEC file number:** 802-114677
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/300039

## About

Early-Stage Biotechnology Ventures | Pandect Bioventures is venture capital firm providing seed to Series A and later funding to early-stage biotech and pharma companies, along with full management support to help entrepreneurs achieve critical business milestones.

## Sectors

- Digital Health
- Enterprise Software

## Questions

### What investment stages does Pandect Bioventures target?

Pandect deploys capital across the full early-stage continuum, including seed, start-up, and expansion rounds, per its stated strategy. The firm also participates in later-stage growth financings and corporate divestitures. This stage-agnostic approach within early-stage life sciences allows the firm to follow portfolio companies from formation through clinical development.

### Does Pandect Bioventures lead rounds or co-invest?

The firm's strategy includes both lead and co-investor roles, as indicated by its broad stage coverage and venture generalist posture. Without detailed portfolio disclosures, the precise balance between leading and following is not publicly documented. Allocators evaluating the firm should clarify syndication preferences during direct diligence.

### Where is Pandect Bioventures located and why does geography matter?

Pandect is headquartered in South San Francisco, the historical birthplace of Genentech and the densest biotech cluster in the world. Proximity to UCSF, Stanford, and the South San Francisco life sciences corridor is a structural advantage for proprietary deal flow. The firm's location positions it to source pre-institutional academic spin-outs and early commercial-stage companies.

## Related profiles

- [Pandan Ventures](https://altss.com/profile/pandan-ventures)
- [Pandion Mine Finance](https://altss.com/profile/pandion-mine-finance)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/pandect-bioventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology